| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.005 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.69 | 0.009 |